QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$26.99 USD
+0.18 (0.67%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $27.00 +0.01 (0.04%) 7:58 PM ET
5-Strong Sell of 5 5
B Value D Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
QDEL 26.99 +0.18(0.67%)
Will QDEL be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for QDEL based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for QDEL
Baxter International (BAX) Beats Q3 Earnings Estimates
GE HealthCare Technologies (GEHC) Surpasses Q3 Earnings and Revenue Estimates
QDEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test
Medtronic (MDT) Up 1.5% Since Last Earnings Report: Can It Continue?
Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term
Other News for QDEL
MACD Bearish Centerline Cross appears for QDEL after 0.67% move
QDEL's price falls by 4.04% on October 30, though its technical setup remains stable.
QDEL forms 20 Day Moving Average Resistance on October 29
Fell Below 20 Day Moving Average appears for QDEL after 4.38% move
QDEL forms Stochastic Reached Overbought on October 27